Pharmaceutical Technology

APRIL 24, 2023

Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. Studying the behaviour of animals can aid in drug discovery research too.

Medicine 105

Medicine Side effects Healthcare Healthcare 105

Pharmaceutical Technology

MAY 18, 2023

The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.

Medicine 99

Medicine Specialization Networking Patients 99

European Pharmaceutical Review

MAY 18, 2023

A new document published by European Medicines Agency (EMA) makes ten recommendations and outlines good practices “to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact.” Medicine shortages are a global health problem and are increasingly affecting European countries, according to EMA.

Medicine 98

Medicine Distribution Manufacturing Management 98

European Pharmaceutical Review

NOVEMBER 15, 2023

[Sandoz] has the only major remaining vertically-integrated production network for penicillins in Europe” Penicillins are the leading category of antibiotics worldwide, Sandoz highlighted. The post Sandoz mobilises critical medicine production in Europe appeared first on European Pharmaceutical Review.

Medicine 93

Medicine Manufacturing Networking Biopharma 93

Pharmaceutical Technology

MAY 24, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Recombinant viral vector-based medicinal preparations. However, not all innovations are equal and nor do they follow a constant upward trend.

Medicine 52

Medicine Pharmaceutical Leads Prescription 52

European Pharmaceutical Review

FEBRUARY 21, 2023

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. In this Q&A, EPR caught up with CEO James Short and Managing Director Arthur Wakeley from Celadon, to learn more about the company’s experience moving through, and progressing, the strict regulatory process for medicinal cannabis.

Medicine 132

Medicine Manufacturing Specialization Pharmaceutical 132

pharmaphorum

JANUARY 17, 2023

Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify. Unify, launched in December 2020, is AstraZeneca’s patient app and clinical trial support tool.

Medicine 98

Medicine Patients Transportation Healthcare 98

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,

Medicine 111

Medicine Management Marketing Leads 111

European Pharmaceutical Review

JANUARY 11, 2024

What are the key current challenges in the development of pain medicines? What is the present clinical landscape for pain management medicines, especially chronic pain? Pain management therapies: Pfizer’s migraine medicine recommended by NICE What are three current development trends for pain management treatments?

Medicine 102

Medicine Pharmacology Management Side effects 102

Pharmaceutical Technology

MARCH 27, 2023

Regenerative medicines in early-stage development (preclinical, discovery, or investigational new drug [IND]/ clinical trial application [CTA] filed status) have seen a change in drug targets compared to therapies in late-stage development (Phase II to pre-registration stage).

Medicine 98

Medicine Marketing Leads 98

Fierce Pharma

OCTOBER 10, 2023

Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies.

Prospecting 273

Prospecting Manufacturing Medicine Leads 273

MedCity News

SEPTEMBER 20, 2023

This accelerates lead identification and optimization, offering researchers a broader pool of candidates to choose from. From revolutionizing drug discovery and design to enabling personalized medicine and accelerating research, the benefits are vast and diverse.

Ethics 108

Ethics Medicine Pharmaceutical Pharmaceutical research 108

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in personalized cancer vaccines for the pharmaceutical industry.

Leads 52

Leads Medicine Pharmaceutical 52

MedCity News

JULY 7, 2023

This includes mental health, physical medicine and rehabilitation and pain medicine, which all had a more than 20% higher follow-up rate after an in-person office appointment than a telehealth appointment.

Leads 127

Leads Medicine 127

European Pharmaceutical Review

JANUARY 18, 2023

Pfizer has announced it is expanding its ‘An Accord for a Healthier World’ initiative, to include its full portfolio of medicines and vaccines for which Pfizer has global rights. The initial not-for-profit offering provided access to all its patented medicines and vaccines available in the US or European Union (EU) to 1.2

Medicine 98

Medicine Government Pharma Leads 98

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Worldwide sourcing and drop-ship of orphan medicines, and. Worldwide sourcing and drop-ship of orphan medicines, and.

Leads 52

Leads Pharmaceutical Customer Relationship Management Retail 52

Fierce Pharma

JUNE 6, 2024

Amid a nuclear medicine boom, France’s Orano Med has chosen the U.S. The site marks the world’s first industrial-scale facility dedicated to production of lead-212-based radioligand therapies, the company said. to establish a manufacturing plant as it progresses on its radiopharma journey.

Manufacturing 188

Manufacturing Medicine Leads 188

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology. Optimise your cell therapy process: a guide to cell thawing.

Medicine 131

Medicine Pharmaceutical Marketing Sales 131

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. The evolving field of genomic medicine. This is just the beginning; the potential is enormous,” he says.

Medicine 90

Medicine Patients Healthcare Healthcare 90

European Pharmaceutical Review

JUNE 14, 2023

To be a superpower globally, the UK life sciences sector must not only discover and develop medicines of the future domestically, but also manufacture a significant share in the country too, according to a new report from the Medicines Manufacturing Industry Partnership (MMIP). It provides almost 45 percent of the £36.9

Medicine 52

Medicine Manufacturing Government Competition 52

PharmaTech

OCTOBER 6, 2023

The BioIndustry Association reports that with a strong foundation in research and development in mRNA the United Kingdom will be a major player in this rapidly growing industry.

Leads 52

Leads Medicine 52

Fierce Pharma

NOVEMBER 1, 2023

In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky talks with the study lead, Reisa Sperling, M.D., to learn more.

Medicine 175

Medicine Leads 175

pharmaphorum

JANUARY 27, 2023

So, here are three “best guesses” for what 2023 will hold for the off-patent medicines segment — which accounts for roughly 70% of medicines prescribed worldwide (including the vast majority of system-critical antibiotics and ICU therapies), but only about 20% of the total cost.

Medicine 88

Medicine Government Marketing Transportation 88

pharmaphorum

OCTOBER 12, 2022

The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine. The group will be leading a workshop on the topic at Frontiers Health next week. Translational medicine and digital health.

Medicine 102

Medicine Training Education Healthcare 102

Nixon Gwilt Law

JUNE 27, 2024

At the most recent Food as Medicine (FaM) Summit, leading experts, policymakers, and healthcare innovators in FaM gathered to discuss one important goal: revolutionizing how we improve population health through food and nutritional guidance. Food as Medicine: Why Should We Care? healthcare and cause more than 1.7

Food 40

Food Medicine Healthcare Healthcare 40

pharmaphorum

NOVEMBER 18, 2022

Gene-testing specialist Editas Medicine has halted development of its lead clinical programme for congenital eye disorders after it generated lacklustre results in a phase 1/2 trial. The post After disappointing trial, Editas puts lead CRISPR drug up for sale appeared first on.

Leads 92

Leads Sales Medicine Patients 92

MedCity News

JULY 12, 2023

That’s why I left traditional medicine. Providers just aren’t given the time it takes to build rapport and ask the right questions within the fee-for-service model. Providers like me who now work in an employer healthcare model can truly help people versus treating them reactively.

Healthcare 83

Healthcare Healthcare Leads Patients 83

Pharmaceutical Technology

JUNE 20, 2023

The Department of Health Abu Dhabi (DoH) has signed a memorandum of understanding with integrated healthcare company M42 and AbbVie Biopharmaceuticals to advance personalised medicine and genomics in the city. M42 was created through the combination of Mubadala Health and G42 Healthcare.

Medicine 52

Medicine Healthcare Healthcare Patients 52

World of DTC Marketing

JUNE 5, 2021

There is disagreement whether obesity is really considered a disease or a behavioral risk factor, similar to smoking, alcohol, and substance abuse that may lead to disease. Some of the environmental conditions that lead to obesity are physical activity, alcohol consumption, socioeconomic status, parent feeding behavior, and diet.

Government 193

Government Medicine Food Management 193

European Pharmaceutical Review

DECEMBER 22, 2022

Advances in mRNA technologies and cellular delivery systems coupled with their cost effectiveness, manufacturing simplicity and ability to target previously-undruggable pathways has limitless potential that could revolutionise medicine. 2022) The Progress and Promise of RNA Medicine – An Arsenal of Targeted Treatments. References.

Medicine 116

Medicine Food and Drug Administration Transportation Distribution 116

Pharmaceutical Technology

NOVEMBER 1, 2022

Intrinsic Medicine has signed a definitive business combination agreement with special purpose acquisition (SPAC) firm Phoenix Biotech Acquisition to create a public company. To be named Intrinsic Medicine following closing, the combined company will be led by current Intrinsic CEO Alexander Martinez and president and COO Jason Ferrone.

Medicine 59

Medicine Safety Specialization Leads 59

MedCity News

APRIL 17, 2023

Merck is acquiring Prometheus Biosciences and a lead drug candidate in development for inflammatory bowel disorders. The deal comes as Merck looks for drug prospects that could make up for revenue declines facing blockbuster seller Keytruda, which faces patent expirations in coming years.

Medicine 94

Medicine Prospecting Leads Biopharma 94

PharmaVoice

AUGUST 29, 2022

Rachel Meyers, chief scientific officer at Faze Medicines, is helping guide the company towards the development of biomolecular condensates — an emerging field that could transform drug discovery.

Leads 98

Leads Medicine 98

Pharmaceutical Technology

JUNE 4, 2023

The company's lead gene therapies are idecabtagene vicleucel and elivaldogene autotemcel which were developed based on lentivirus vectors. The company has developed various assets based on lentivirus vectors.

Leads 98

Leads Pharmaceutical Medicine Medical 98

Pharmaceutical Technology

JULY 1, 2022

Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. Under the deal, Blueprint Medicines will receive an upfront cash payment of $175m as well as up to $165m in potential milestone payments contingent on sales in the future.

Medicine 59

Medicine Food and Drug Administration FDA Prospecting 59

European Pharmaceutical Review

MARCH 8, 2023

Ekaterina received her medical degree from St Petersburg Medical Academy in St Petersburg, Russia, and then moved to the US where she completed her Internal Medicine residency training. She worked in private practice, academic medicine and public health for more than 15 years in the greater New York area.

Leads 52

Leads Pharma Food and Drug Administration Medicine 52

Pharmaceutical Technology

FEBRUARY 15, 2023

Sanofi is one of the leading patent filers working with viral vectors. Genomic medicine researchers at Sanofi are accelerating progress toward gene and cell therapies using an array of technologies, from nucleic acid nanostructures to viral and non-viral gene-delivery platforms.

Leads 98

Leads Pharmaceutical Medicine 98